Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 19-45 years of age, male or female~* presumed diagnosis of urogenital C. trachomatis infection~* use condoms during sexual activity during study (enrollment thru day 28)~Exclusion Criteria:~* Clinical diagnosis pelvic inflammatory disease or epididymitis at baseline~* Diagnosis of N. gonorrhoea~* HIV infection~* Active Hepatitis B or C infection~* Prior hysterectomy (partial or total)~* Treatment with antimicrobial therapy with known activity against urogenital C. trachomatis within 28 days of enrollment

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Doxycycline Hyclate 200 mg tablet (Type: EXPERIMENTAL): Once daily
- Vibramycin 100 mg capsule (Type: ACTIVE_COMPARATOR): Twice daily

Based on this trial design, predict the completion outcome and termination type (if applicable).